Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q3)Dec 31, 2025 | (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.64%848.35M | 33.77%820.44M | 20.07%844.42M | -4.57%3.3B | -24.28%728.11M | 9.96%740.01M | -25.88%613.34M | -25.88%703.28M | 198.23%3.46B | 202.96%961.61M |
| Total premiums earned | 32.94%748.29M | 8.58%654.25M | 18.69%674.75M | 1.88%2.89B | -16.00%623.22M | 12.11%562.89M | -20.70%602.54M | -23.32%568.5M | 261.93%2.84B | 168.05%741.94M |
| -Net premiums written | 32.94%748.29M | 8.58%654.25M | 18.69%674.75M | 1.88%2.89B | -16.00%623.22M | 12.11%562.89M | -20.70%602.54M | -23.32%568.5M | 438.53%2.84B | 155.06%741.94M |
| -Increase decrease in net unearned premium reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 70.23%437.99M | ---- |
| Net investment income | 55.91%-6.26M | 33.23%48.63M | 381.31%103.22M | -84.30%22.61M | -158.76%-29.86M | -117.63%-14.2M | 189.75%36.5M | -60.69%21.45M | 456.06%143.99M | -21.49%50.81M |
| Net realized gain loss on investments | -90.09%578K | -42.63%6.47M | -2,611.54%-16.22M | 456.72%9.31M | -138.52%-5.2M | 470.09%5.83M | 2,223.35%11.28M | 95.12%-598K | -428.84%-2.61M | 1,524.82%13.49M |
| Fees and commission income | 97.03%13.78M | 29.24%6.17M | 53.00%7.3M | 26.07%7.51M | -9.56%20.56M | 211.41%6.99M | -76.33%4.77M | -72.32%4.77M | 38.19%5.96M | 229.72%22.73M |
| Total interest income | 15.12%109.5M | -5.79%113.27M | -1.24%108.39M | 6.54%444.21M | -2.85%105.23M | -9.91%95.12M | 14.62%120.23M | 11.81%109.76M | 29.47%416.96M | 16.37%108.32M |
| Other income expense | -121.04%-17.54M | 94.85%-8.34M | -5,496.61%-33.02M | -246.16%-77.47M | -41.79%14.16M | 934.46%83.37M | -901.47%-161.97M | -101.18%-590K | 146.50%53M | 43.47%24.32M |
| Total expenses | 11.44%676.62M | 36.79%691.31M | 8.82%651.67M | -3.60%2.84B | -9.11%626.35M | 5.49%607.16M | -34.80%505.36M | -30.80%598.86M | 190.91%2.95B | 167.94%689.15M |
| Policy acquisition expense | ---- | ---- | ---- | 5.50%349.07M | ---- | ---- | ---- | ---- | 161.19%330.86M | ---- |
| Net policyholder benefits and claims | 41.16%638.78M | 15.05%714.62M | -8.38%580.59M | 6.75%2.1B | 19.12%624.8M | -11.10%452.52M | -13.69%621.16M | -22.25%633.73M | -10.54%1.97B | 225.05%524.52M |
| Change in insurance liabilities, net of reinsurance | -85.34%20.9M | 73.48%-37.6M | 183.35%51.35M | -23.77%347.33M | -202.55%-99.95M | -31.05%142.53M | -364.34%-141.78M | -353.33%-61.61M | 131.93%455.66M | 97.30%-33.04M |
| Change in investment contract | ---- | ---- | ---- | -22.43%7.28M | ---- | ---- | ---- | ---- | 315.53%9.38M | ---- |
| Other operating expenses | 452.36%15.66M | -36.87%13.02M | -6.62%29.3M | -91.97%16.13M | -56.72%96.05M | 96.88%-4.44M | 366.10%20.62M | 20.20%31.37M | 77.51%200.86M | 514.50%221.94M |
| Income from associates and other participating interests | 163.55%6.16M | -62.69%2.96M | 81.83%15.67M | -85.50%6.47M | -101.09%-389K | -302.63%-9.7M | 397.97%7.94M | 24.55%8.62M | 179.16%44.62M | 57.75%35.58M |
| Special income (charges) | ---- | 162.49%2.63M | -55.65%1.76M | 587.05%1.88M | 99.77%-11K | ---- | ---4.2M | --3.97M | -111.56%-386K | ---4.74M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 70.83%-21K | ---- |
| -Less:Other special charges | ---- | -162.49%-2.63M | 55.65%-1.76M | -561.92%-1.88M | -99.77%11K | ---- | --4.2M | ---3.97M | 112.46%407K | --4.74M |
| Net non-operating interest income (expenses) | -8.70%-7.45M | 24.62%-6.86M | 1.21%-7.87M | -6.26%-28.98M | 23.02%-5.05M | 1.83%-6.85M | -32.33%-9.1M | -16.06%-7.96M | -26.22%-27.27M | 5.00%-6.56M |
| -Non-operating interest expense | 8.70%7.45M | -24.62%6.86M | -1.21%7.87M | 6.26%28.98M | -23.02%5.05M | -1.83%6.85M | 32.33%9.1M | 16.06%7.96M | 26.22%27.27M | -5.00%6.56M |
| Income before tax | 22.58%171.73M | 19.59%129.13M | 84.59%192.75M | -10.19%454.25M | -62.65%101.76M | 43.85%140.1M | 105.97%107.98M | 25.05%104.42M | 249.58%505.78M | 238.88%272.47M |
| Income tax | -14.32%20.77M | 10.66%16.87M | 99.13%24.32M | -16.94%60M | -75.86%8.36M | 89.65%24.24M | 40.36%15.24M | -12.52%12.21M | 173.60%72.24M | 252.67%34.64M |
| Net income | 30.30%150.97M | 21.06%112.27M | 82.67%168.43M | -9.06%394.25M | -60.73%93.4M | 36.93%115.86M | 123.11%92.74M | 32.60%92.2M | 266.54%433.54M | 236.96%237.82M |
| Net income continuous operations | 30.30%150.97M | 21.06%112.27M | 82.67%168.43M | -9.06%394.25M | -60.73%93.4M | 36.93%115.86M | 123.11%92.74M | 32.60%92.2M | 266.54%433.54M | 236.96%237.82M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 30.30%150.97M | 21.06%112.27M | 82.67%168.43M | -9.06%394.25M | -60.73%93.4M | 36.93%115.86M | 123.11%92.74M | 32.60%92.2M | 266.54%433.54M | 236.96%237.82M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 30.30%150.97M | 21.06%112.27M | 82.67%168.43M | -9.06%394.25M | -60.73%93.4M | 36.93%115.86M | 123.11%92.74M | 32.60%92.2M | 266.54%433.54M | 236.96%237.82M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 30.27%0.1928 | 21.11%0.1434 | 82.75%0.2151 | -9.21%0.503 | -60.72%0.1193 | 37.04%0.148 | 122.98%0.1184 | 32.55%0.1177 | 266.89%0.554 | 237.07%0.3037 |
| Diluted earnings per share | 30.27%0.1928 | 21.11%0.1434 | 82.75%0.2151 | -9.21%0.503 | -60.72%0.1193 | 37.04%0.148 | 122.98%0.1184 | 32.55%0.1177 | 266.89%0.554 | 237.07%0.3037 |
| Dividend per share | 0 | 0.05 | 0 | 12.36%0.05 | 0 | 12.36%0.05 | 0 | 0 | 78.00%0.0445 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.